Cosela (Trilaciclib Dihydrochloride) Patent Expiration, LOE Window & CMS Spending

Cosela (Trilaciclib Dihydrochloride) by Pharmacosmos As: FDA Orange Book core substance LOE 2040-11-13, 0 AB generics, $4.3M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPharmacosmos As
FDA Application & PathwayN214200 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2040-11-13
Last Listed Patent or Exclusivity Date2040-11-13
Orange Book Patents (*PED Extensions)14 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$4.3M
2024 Medicare Part D Spend$99K
2024 Medicaid Spend$4.2M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 16.6% 2-yr change)